iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma
Abstract Background Cytokine-induced memory-like natural killer (CIML NK) cells have been found to possess potent antitumor responses and induce complete remissions in patients with leukemia. However, the poor infiltration of transferred NK cells is a major obstacle in developing adoptive cell immun...
| 出版年: | Journal of Translational Medicine |
|---|---|
| 主要な著者: | Yanbing Dong, Ying Huang, Zhe Zhang, Aoxing Chen, Lin Li, Manman Tian, Jie Shen, Jie Shao |
| フォーマット: | 論文 |
| 言語: | 英語 |
| 出版事項: |
BMC
2023-03-01
|
| 主題: | |
| オンライン・アクセス: | https://doi.org/10.1186/s12967-023-04024-7 |
類似資料
Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation
著者:: Jie Shao, 等
出版事項: (2024-12-01)
著者:: Jie Shao, 等
出版事項: (2024-12-01)
Tumor-specific delivery of KRAS siRNA with iRGD-exosomes efficiently inhibits tumor growth
著者:: Yu Zhou, 等
出版事項: (2019-12-01)
著者:: Yu Zhou, 等
出版事項: (2019-12-01)
iRGD‐Targeted Physalis Mottle Virus Like Nanoparticles for Targeted Cancer Delivery
著者:: Krister J. Barkovich, 等
出版事項: (2023-08-01)
著者:: Krister J. Barkovich, 等
出版事項: (2023-08-01)
Dual Effect of Chemo-PDT with Tumor Targeting Nanoparticles Containing iRGD Peptide
著者:: Gye Lim Kim, 等
出版事項: (2023-02-01)
著者:: Gye Lim Kim, 等
出版事項: (2023-02-01)
Correction: iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma
著者:: Yanbing Dong, 等
出版事項: (2023-05-01)
著者:: Yanbing Dong, 等
出版事項: (2023-05-01)
Tumor Microenvironment-Responsive Polymeric iRGD and Doxorubicin Conjugates Reduce Spontaneous Lung Metastasis in an Orthotopic Breast Cancer Model
著者:: Zheng-Hong Peng, 等
出版事項: (2022-08-01)
著者:: Zheng-Hong Peng, 等
出版事項: (2022-08-01)
iRGD-Targeted Biosynthetic Nanobubbles for Ultrasound Molecular Imaging of Osteosarcoma
著者:: Liu T, 等
出版事項: (2025-01-01)
著者:: Liu T, 等
出版事項: (2025-01-01)
iRGD‐modified exosomes effectively deliver CPT1A siRNA to colon cancer cells, reversing oxaliplatin resistance by regulating fatty acid oxidation
著者:: Dan Lin, 等
出版事項: (2021-12-01)
著者:: Dan Lin, 等
出版事項: (2021-12-01)
Zerumbone Induces Apoptosis in Breast Cancer Cells by Targeting αvβ3 Integrin upon Co-Administration with TP5-iRGD Peptide
著者:: Eltayeb E. M. Eid, 等
出版事項: (2019-07-01)
著者:: Eltayeb E. M. Eid, 等
出版事項: (2019-07-01)
Preparation and characterization of a iRGD-modified recombinant spider silk particles for antitumor polypeptide drug delivery into cancer cells
著者:: Ben Wang, 等
出版事項: (2025-08-01)
著者:: Ben Wang, 等
出版事項: (2025-08-01)
The Antitumour Activity of a Curcumin and Piperine Loaded iRGD-Modified Liposome: In Vitro and In Vivo Evaluation
著者:: Yingzheng Wang, 等
出版事項: (2023-09-01)
著者:: Yingzheng Wang, 等
出版事項: (2023-09-01)
Stabilized iRGD modification enhances NY-ESO-1 TCR-T infiltration in solid tumors and synergizes with PD-1 blockade
著者:: Yirong Wu, 等
出版事項: (2025-05-01)
著者:: Yirong Wu, 等
出版事項: (2025-05-01)
Molecular Imaging of Steroid-Induced Osteonecrosis of the Femoral Head through iRGD-Targeted Microbubbles
著者:: Ping Zhao, 等
出版事項: (2022-09-01)
著者:: Ping Zhao, 等
出版事項: (2022-09-01)
Characterization of iRGD-Ligand Modified Arginine-Histidine-Rich Peptides for Nucleic Acid Therapeutics Delivery to αvβ3 Integrin-Expressing Cancer Cells
著者:: Anna Egorova, 等
出版事項: (2020-10-01)
著者:: Anna Egorova, 等
出版事項: (2020-10-01)
Anticancer activity of Pseudomonas aeruginosa derived peptide with iRGD in colon cancer therapy
著者:: Atieh Yaghoubi, 等
出版事項: (2023-07-01)
著者:: Atieh Yaghoubi, 等
出版事項: (2023-07-01)
ASCEND: a randomised, double-blinded, placebo-controlled, phase II study of gemcitabine and nab-paclitaxel with LSTA1 in untreated metastatic pancreatic adenocarcinoma. An Australasian Gastro-Intestinal Trials Group (AGITG) trial✰
著者:: J. Lee, 等
出版事項: (2023-10-01)
著者:: J. Lee, 等
出版事項: (2023-10-01)
iRGD-Guided Silica/Gold Nanoparticles for Efficient Tumor-Targeting and Enhancing Antitumor Efficacy Against Breast Cancer
著者:: Hou X, 等
出版事項: (2024-08-01)
著者:: Hou X, 等
出版事項: (2024-08-01)
HER-2 Receptor and αvβ3 Integrin Dual-Ligand Surface-Functionalized Liposome for Metastatic Breast Cancer Therapy
著者:: Dilip Kumar Arya, 等
出版事項: (2024-08-01)
著者:: Dilip Kumar Arya, 等
出版事項: (2024-08-01)
αvβ3 Integrin and Folate-Targeted pH-Sensitive Liposomes with Dual Ligand Modification for Metastatic Breast Cancer Treatment
著者:: Prashant Pandey, 等
出版事項: (2024-08-01)
著者:: Prashant Pandey, 等
出版事項: (2024-08-01)
Peptide-Based Nanoparticles for αvβ3 Integrin-Targeted DNA Delivery to Cancer and Uterine Leiomyoma Cells
著者:: Anna Egorova, 等
出版事項: (2022-11-01)
著者:: Anna Egorova, 等
出版事項: (2022-11-01)
Therapeutic and diagnostic implications of exosomes as natural nanoparticles: a new paradigm in brain cancer disease management
著者:: Shanid Mohiyuddin, 等
出版事項: (2025-07-01)
著者:: Shanid Mohiyuddin, 等
出版事項: (2025-07-01)
Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in miceResearch in context
著者:: Christian Schmithals, 等
出版事項: (2024-07-01)
著者:: Christian Schmithals, 等
出版事項: (2024-07-01)
The construction of in vitro nasal cavity-mimic M-cell model, design of M cell-targeting nanoparticles and evaluation of mucosal vaccination by nasal administration
著者:: Xiaotong Yang, 等
出版事項: (2020-06-01)
著者:: Xiaotong Yang, 等
出版事項: (2020-06-01)
iRGD Tumor-Penetrating Peptide-Modified Nano-Delivery System Based on a Marine Sulfated Polysaccharide for Enhanced Anti-Tumor Efficiency Against Breast Cancer
著者:: Chen B, 等
出版事項: (2022-02-01)
著者:: Chen B, 等
出版事項: (2022-02-01)
Targeting vascular disrupting agent-treated tumor microenvironment with tissue-penetrating nanotherapy
著者:: Valeria Sidorenko, 等
出版事項: (2024-07-01)
著者:: Valeria Sidorenko, 等
出版事項: (2024-07-01)
Engineering a HEK-293T exosome-based delivery platform for efficient tumor-targeting chemotherapy/internal irradiation combination therapy
著者:: Congcong Wang, 等
出版事項: (2022-05-01)
著者:: Congcong Wang, 等
出版事項: (2022-05-01)
MicroRNA-539-5p-Loaded PLGA Nanoparticles Grafted with iRGD as a Targeting Treatment for Choroidal Neovascularization
著者:: Jouri S. Alanazi, 等
出版事項: (2022-01-01)
著者:: Jouri S. Alanazi, 等
出版事項: (2022-01-01)
Dual-Modality Molecular Imaging of Tumor via Quantum Dots-Liposome–Microbubble Complexes
著者:: Jieqiong Wang, 等
出版事項: (2022-11-01)
著者:: Jieqiong Wang, 等
出版事項: (2022-11-01)
Synergistic Pro-Apoptotic Effect of a Cyclic RGD Peptide-Conjugated Magnetic Mesoporous Therapeutic Nanosystem on Hepatocellular Carcinoma HepG2 Cells
著者:: Xuanping Zhao, 等
出版事項: (2023-01-01)
著者:: Xuanping Zhao, 等
出版事項: (2023-01-01)
Characterizing hepatocellular carcinoma stem markers and their corresponding susceptibility to NK-cell based immunotherapy
著者:: Jason Chiang, 等
出版事項: (2023-10-01)
著者:: Jason Chiang, 等
出版事項: (2023-10-01)
Multimeric RGD-Based Strategies for Selective Drug Delivery to Tumor Tissues
著者:: Jordan Cossu, 等
出版事項: (2023-02-01)
著者:: Jordan Cossu, 等
出版事項: (2023-02-01)
Click Chemistry for the Synthesis of RGD-Containing Integrin Ligands
著者:: Matteo Colombo, 等
出版事項: (2010-01-01)
著者:: Matteo Colombo, 等
出版事項: (2010-01-01)
Low-Molecular Weight Polyethylenimine Modified with Pluronic 123 and RGD- or Chimeric RGD-NLS Peptide: Characteristics and Transfection Efficacy of Their Complexes with Plasmid DNA
著者:: Jing Hu, 等
出版事項: (2016-05-01)
著者:: Jing Hu, 等
出版事項: (2016-05-01)
Design of Functional RGD Peptide-Based Biomaterials for Tissue Engineering
著者:: Vijay Bhooshan Kumar, 等
出版事項: (2023-01-01)
著者:: Vijay Bhooshan Kumar, 等
出版事項: (2023-01-01)
Histomorphometry of Ossification in Functionalised Ceramics with Tripeptide Arg-Gly-Asp (RGD): An In Vivo Study
著者:: Filippo Migliorini, 等
出版事項: (2022-05-01)
著者:: Filippo Migliorini, 等
出版事項: (2022-05-01)
Photodynamic Therapy Using RGD-Functionalized Quantum Dots Elicit a Potent Immune Response in a Syngeneic Mouse Model of Pancreatic Cancer
著者:: Li MM, 等
出版事項: (2024-09-01)
著者:: Li MM, 等
出版事項: (2024-09-01)
Status and Advances of RGD Molecular Imaging in Lung Cancer
著者:: Ning YUE, 等
出版事項: (2014-12-01)
著者:: Ning YUE, 等
出版事項: (2014-12-01)
New opportunities for RGD-engineered metal nanoparticles in cancer
著者:: Wei Qin, 等
出版事項: (2023-05-01)
著者:: Wei Qin, 等
出版事項: (2023-05-01)
Design and synthesis of hydrophobic RGD-peptides derivatives
著者:: A. V. Dobrynina, 等
出版事項: (2010-02-01)
著者:: A. V. Dobrynina, 等
出版事項: (2010-02-01)
LIC12254 Is a Leptospiral Protein That Interacts with Integrins via the RGD Motif
著者:: Maria F. Cavenague, 等
出版事項: (2023-04-01)
著者:: Maria F. Cavenague, 等
出版事項: (2023-04-01)
類似資料
-
Combining iRGD with HuFOLactis enhances antitumor potency by facilitating immune cell infiltration and activation
著者:: Jie Shao, 等
出版事項: (2024-12-01) -
Tumor-specific delivery of KRAS siRNA with iRGD-exosomes efficiently inhibits tumor growth
著者:: Yu Zhou, 等
出版事項: (2019-12-01) -
iRGD‐Targeted Physalis Mottle Virus Like Nanoparticles for Targeted Cancer Delivery
著者:: Krister J. Barkovich, 等
出版事項: (2023-08-01) -
Dual Effect of Chemo-PDT with Tumor Targeting Nanoparticles Containing iRGD Peptide
著者:: Gye Lim Kim, 等
出版事項: (2023-02-01) -
Correction: iRGD-modified memory-like NK cells exhibit potent responses to hepatocellular carcinoma
著者:: Yanbing Dong, 等
出版事項: (2023-05-01)
